IDO1-IN-19
IDO1-IN-19 (Compound 17) is an orally active IDO1 inhibitor with an IC50 of CYP2C9 of 8.64 μM. IDO1-IN-19 also acts funciton on cardiac channels, with IC50s of 12 μM (IKr), 40 μM (INa), 8.3 μM (ICa), respectively. IDO1-IN-19 has the potential to study cancer diseases[1].
Product Specifications
CAS Number
[2328099-11-0]
UNSPSC
12352005
Target
Calcium Channel; Cytochrome P450; Indoleamine 2,3-Dioxygenase (IDO) ; Potassium Channel; Sodium Channel
Type
Reference compound
Related Pathways
Membrane Transporter/Ion Channel; Metabolic Enzyme/Protease; Neuronal Signaling
Applications
Cancer-programmed cell death
Field of Research
Cancer; Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/ido1-in-19.html
Purity
98.82
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
OC(C)(C)C1=CC(C(F)(F)F)=NC=C1C2=CC=C(C3(COC3)C(NC4=CC=C(F)C=C4)=O)C=C2
Molecular Formula
C25H22F4N2O3
Molecular Weight
474.45
References & Citations
[1]Derun Li, et al. Oxetane Promise Delivered: Discovery of Long-Acting IDO1 Inhibitors Suitable for Q3W Oral or Parenteral Dosing.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
Calcium Channel; CYP2; IDO1; Inwardly rectifying potassium channel
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
STAP1, NT (F56) (BRDG1, Signal-transducing Adaptor Protein 1, Stem Cell Adaptor Protein 1, BCR Downstream-signaling Protein 1, Docking Protein BRDG1) (PE) discontinued
Recombinant Aeromonas hydrophila subsp. hydrophila ATP synthase subunit delta (atpH)
Recombinant Aeromonas hydrophila subsp. hydrophila ATP synthase subunit delta (atpH)
Recombinant Aeromonas hydrophila subsp. hydrophila ATP synthase subunit delta (atpH)